Evaluation of the effects and safety of the use of the Youridm on muscle pain in adult (single center, randomized trial)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004658

Enrollment

Registered

2020-01-28

Start date

2020-01-06

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : 1. Clinical trial device : CGM MBD-1201 2. Management : Subjects performed the following 20 treatments according to the randomly assigned group. - Experimental group : CGM MBD-1201

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adult men and women with muscle pain on neck, shoulder, and lower back 2) Subjects who are determined to be suitable in the screening test 3) Subjects who have received a detailed explanation of the study and completed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with muscle pain due to diseases of other organs such as liver disease, cancer, rheumatic diseases, thyroid diseases, etc. 2) myopathy 3) Malignant tumor, spinal cord infection, or thrombosis 4) Skin disease and hypersensitivity 5) Reduced skin sensation 6) Those who have received other investigational drugs or are applying the investigational medical device 30 days before the start of the clinical trial 7) A person deemed inappropriate as a clinical trial subject when judged by the investigator

Design outcomes

Primary

Measure	Time frame
Surface EMG	—

Secondary

Measure	Time frame
Pain Disability Index;Beck Depression Inventory;Digital Pain Scale;Inbody;Korean Version of the Pittsburgh Sleep Quality Index;Abdominal circumference	—

Countries

Korea, Republic of

Contacts

Public ContactJi Sun Oh

Presbyterian Medical Center

Outcome results